JMP Securities Sticks to Their Buy Rating for NICE (NICE)
JMP Securities analyst Patrick Walravens maintained a Buy rating on NICE (NICE – Research Report) today and set a price target of $300.00. The ...
JMP Securities Keeps Their Buy Rating on Halozyme (HALO)
In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on Halozyme (HALO – Research Report), with a price target ...